Jingyi Liu

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Jyoti D. Patel, Mark A. Socinski, Edward B. Garon et al. · Journal of Clinical Oncology · 2013 · 374 citations · Full text

Medicine, Oncology, Pharmacology +13

The Children's Sleep Habits Questionnaire in Toddlers and Preschool Children

Beth L. Goodlin‐Jones, Stephanie L. Sitnick, Karen Tang et al. · Journal of Developmental & Behavioral Pediatrics · 2008 · 364 citations

Medicine, Child Health, Pediatrics +17

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Ralph Zinner, Coleman K. Obasaju, David R. Spigel et al. · Journal of Thoracic Oncology · 2014 · 173 citations · Full text

Medicine, Oncology, Pharmacology +5

Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart

Wenjun Yan, Haifeng Zhang, Peilin Liu et al. · Basic Research in Cardiology · 2013 · 172 citations

Life Sciences, Cell Biology, Physiology +14

Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update

Liping Liu, Zixiao Li, Hongyu Zhou et al. · Stroke and Vascular Neurology · 2023 · 157 citations · Full text

Medicine, Neurology, Neurosurgery +17